The global Radiopharmaceuticals Market is poised for significant growth over the next decade, driven by advancements in nuclear medicine, increasing applications in diagnostics and therapy, and the rising prevalence of cancer and cardiovascular diseases. Valued at USD 5.0 billion in 2023, the market is projected to grow at a compound annual growth rate (CAGR) of 10.4%, reaching USD 16.6 billion...